Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nuvig Therapeutics, Inc.

Clinical trials sponsored by Nuvig Therapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug mimics IVIg to fight low platelet disorder Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

New drug mimics IVIg to fight low platelet disorder

Disease control Recruiting now

This study tests a new drug called NVG-2089 in 30 adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. The drug is designed to work like IVIg, calming the immune system. Researchers will check for side effects …

Phase 2 • Sponsor: Nuvig Therapeutics, Inc. • Aim: Disease control

Last updated Sep 16, 2026 00:00 UTC